Clarifying standards for using placebos [2]

Science

Volumn 300, Issue 5626, 2003, Pages 1659-1661

  Levine, Robert J ^a   Carpenter, William T ^b   Appelbaum, Paul S ^c  

^a YALE UNIVERSITY   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLINICAL RESEARCH; LETTER; MEDICAL ETHICS; MEDICAL RESEARCH; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAFETY; STANDARD;

BIOMEDICAL AND BEHAVIORAL RESEARCH; INTERNATIONAL ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH INVOLVING HUMAN SUBJECTS;

CONTROLLED CLINICAL TRIALS; DEVELOPING COUNTRIES; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; EUROPEAN UNION; GUIDELINES; HELSINKI DECLARATION; HUMANS; PLACEBOS;

EID: 0038518215     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.300.5626.1659     Document Type: Letter

References (3)

1. World Medical Association Declaration of Helsinki as amended by the 52nd WNA General Assembly, Edinburgh, Scotland, October 2000; Note of Clarification on Paragraph 29 added by the WMA General Assembly, Washington, DC, 2002.
2. Council for international Organizations of Medical Sciences (CIOMS), International ethical guidelines for biomedical research involving human subjects (CIOMS, Geneva, 1993).
3. W. T. Carpenter, P. S. Appelbaum, R. J. Levine, Am. J. Psychiatry 160, 356 (2003).